Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

URN to cite this document:: urn:nbn:de:bvb:355-epub-361745
DOI to cite this document:: 10.5283/epub.36174

Moinzadeh, P. ; Aberer, E. ; DNNS Centers, all participating ; Landthaler, Michael

Preview

License: Allianz- bzw. Nationallizenz
PDF - Published Version
(1MB)

Date of publication of this fulltext: 08 Sep 2017 12:15

Alternative links to fulltext:DOI

Details

Preview

Export bibliographical data

Abstract

Background: Systemic sclerosis (SSc)-overlap syndromes are a very heterogeneous and remarkable subgroup of SSc-patients, who present at least two connective tissue diseases (CTD) at the same time, usually with a specific autoantibody status. Objectives: To determine whether patients, classified as overlap syndromes, show a disease course different from patients with limited SSc (lcSSc) or diffuse ...